72 related articles for article (PubMed ID: 16469630)
1. New contralateral vesicoureteral reflux following dextranomer/hyaluronic Acid implantation: incidence and identification of a high risk group.
Elmore JM; Kirsch AJ; Lyles RH; Perez-Brayfield MR; Scherz HC
J Urol; 2006 Mar; 175(3 Pt 1):1097-100; discussion 1100-1. PubMed ID: 16469630
[TBL] [Abstract][Full Text] [Related]
2. Is routine voiding cystourethrogram necessary following double hit for primary vesicoureteral reflux?
Arlen AM; Scherz HC; Filimon E; Leong T; Kirsch AJ
J Pediatr Urol; 2015 Feb; 11(1):40.e1-5. PubMed ID: 25725613
[TBL] [Abstract][Full Text] [Related]
3. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
Kirsch AJ; Perez-Brayfield MR; Scherz HC
J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
[TBL] [Abstract][Full Text] [Related]
4. Unilateral vesicoureteral reflux: does endoscopic injection based on the cystoscopic appearance of the ureteral orifice decrease the incidence of de-novo contralateral reflux?
Routh JC; Inman BA; Ashley RA; Vandersteen DR; Reinberg Y; Wolpert JJ; Kramer SA; Husmann DA
J Pediatr Urol; 2008 Aug; 4(4):260-4. PubMed ID: 18644526
[TBL] [Abstract][Full Text] [Related]
5. Selective endoscopic treatment of the non-refluxing contralateral ureter prevents new contralateral vesicoureteral reflux.
Cerwinka WH; Kaye JD; Leong TL; Elmore JM; Scherz HC; Kirsch AJ
J Pediatr Urol; 2013 Feb; 9(1):51-5. PubMed ID: 22177779
[TBL] [Abstract][Full Text] [Related]
6. Dextranomer/hyaluronic acid for vesicoureteral reflux: success rates after initial treatment failure.
Elmore JM; Scherz HC; Kirsch AJ
J Urol; 2006 Feb; 175(2):712-5. PubMed ID: 16407036
[TBL] [Abstract][Full Text] [Related]
7. Utility of dextranomer/hyaluronic acid injection in setting of bladder and ureteral anomalies.
Routh JC; Kramer SA; Inman BA; Ashley RA; Wolpert JJ; Vandersteen DR; Husmann DA; Reinberg Y
Urology; 2008 Mar; 71(3):435-8. PubMed ID: 18342182
[TBL] [Abstract][Full Text] [Related]
8. Are there predictive factors for the outcome of endoscopic treatment of grade III-V vesicoureteral reflux with dextranomer/hyaluronic acid in children?
Altug U; Cakan M; Yilmaz S; Yalçinkaya F
Pediatr Surg Int; 2007 Jun; 23(6):585-9. PubMed ID: 17356857
[TBL] [Abstract][Full Text] [Related]
9. The reliability of VCUG performed within 24 hours after injection of dextranomer/hyaluronic acid in patients with vesico-ureteral reflux.
Oh MM; Park MG; Kim JW; Yoo KH; Lee JW; Yoon CY; Park HS; Moon du G
Urology; 2014 Jan; 83(1):191-4. PubMed ID: 24041674
[TBL] [Abstract][Full Text] [Related]
10. Single center experience with endoscopic management of vesicoureteral reflux in children.
Routh JC; Vandersteen DR; Pfefferle H; Wolpert JJ; Reinberg Y
J Urol; 2006 May; 175(5):1889-92; discussion 1892-3. PubMed ID: 16600790
[TBL] [Abstract][Full Text] [Related]
11. Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation.
Elmore JM; Kirsch AJ; Heiss EA; Gilchrist A; Scherz HC
J Urol; 2008 Jun; 179(6):2364-7; discussion 2367-8. PubMed ID: 18436248
[TBL] [Abstract][Full Text] [Related]
12. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer.
Vandersteen DR; Routh JC; Kirsch AJ; Scherz HC; Ritchey ML; Shapiro E; Wolpert JJ; Pfefferle H; Reinberg Y
J Urol; 2006 Oct; 176(4 Pt 1):1593-5. PubMed ID: 16952696
[TBL] [Abstract][Full Text] [Related]
13. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux.
Chi A; Gupta A; Snodgrass W
J Urol; 2008 May; 179(5):1966-9. PubMed ID: 18355849
[TBL] [Abstract][Full Text] [Related]
14. Subureteral dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux in transplant candidates.
Ozok U; Eroglu M; Imamoglu A; Bakirtaş H; Güvence N; Kiper A
J Endourol; 2005 Dec; 19(10):1185-7. PubMed ID: 16359211
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.
Stenberg A; Larsson E; Läckgren G
J Urol; 2003 Mar; 169(3):1109-13. PubMed ID: 12576864
[TBL] [Abstract][Full Text] [Related]
16. Effective endoscopic diagnosis and treatment of pediatric occult vesicoureteral reflux with intermediate to long-term follow-up.
Arlen AM; Broderick KM; Leong T; Dewhurst LL; Filimon E; Weiss AD; Kirsch AJ
J Pediatr Urol; 2014 Dec; 10(6):1095-9. PubMed ID: 24916577
[TBL] [Abstract][Full Text] [Related]
17. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon.
Yu RN; Roth DR
Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825
[TBL] [Abstract][Full Text] [Related]
18. Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infections in patients with vesicoureteral reflux.
Elder JS; Shah MB; Batiste LR; Eaddy M
Curr Med Res Opin; 2007 Sep; 23 Suppl 4():S15-20. PubMed ID: 17931480
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children.
Cerwinka WH; Scherz HC; Kirsch AJ
J Urol; 2007 Oct; 178(4 Pt 1):1469-73. PubMed ID: 17706704
[TBL] [Abstract][Full Text] [Related]
20. New contralateral vesicoureteral reflux after endoscopic correction of unilateral reflux--is routine contralateral injection indicated at initial treatment?
Menezes M; Mohanan N; Haroun J; Colhoun E; Puri P
J Urol; 2007 Oct; 178(4 Pt 2):1711-3. PubMed ID: 17707017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
